Back to catalogue
№ 295 34 filings · 2021-07-07 → 2026-07-27

QUARTIX TECHNOLOGIES PLC

QTX
Technology Share price 228p Market cap £110m Overall fit 475 /1000

High-quality subscription compounder with fair valuation and strong downside protection, but only tangential AI-beneficiary status and moderate operating leverage limit fit to this investor's AI-receiver / long-tail-upside thesis.

Fair value range 260p–320p Mid case · £141m
Absolute upside +27.9% vs current market cap
Conviction 4/5 confidence in undervalued call
Supports the call
  • 97% recurring revenue with 22-year subscription track record
  • Four consecutive result cycles meeting/beating guidance
  • Multiple valuation methods (P/E, EV/EBITDA, FCF) converge
Limits the call
  • Recent FRC-driven IAS 16 restatement complicates margin history
  • Mature SME market caps terminal growth assumptions
Methodology

Blended forward P/E and EV/EBITDA with DCF cross-check

In one line · bull case

High-quality, net-cash subscription telematics compounder growing ARR 11-14% at ~15x forward earnings, with Continental European expansion providing incremental upside.

In one line · biggest risk

US and UK NRR is drifting, and a further slowdown would materially weaken the compounding thesis that supports the current multiple.

Drivers
AI beneficiary 30 /100
Telematics data has AI training value in theory but no revenue line captures it; one internal AI research project mentioned in H1 2026 [src: 2026-07-27 interim].
Operating leverage 68 /100
80% gross margin and largely fixed opex mean incremental ARR drops through at ~90% gross margin, though management reinvests upside into S&M.
Earnings vs expectations 70 /100
Four consecutive periods of in-line or modest beats since the 2023 Konetik reset; FY26 guidance reaffirmed at H1.
Growth momentum 58 /100
Steady 11-14% ARR growth with continental Europe accelerating (Italy +39%, Spain +31% TTM).
Moat 50 /100
Hardware switching costs, strong Trustpilot score, and 25-year customer service reputation, but no network effects and competitive telematics market.
Earnings quality 65 /100
Cash conversion 104% of EBITDA in 2025; recent IAS 16 restatement and £1.1m prior-year tax charge in H1 2026 modestly dent quality.
Management quality 60 /100
Founder-Chairman refocused business post-Konetik disaster, but that acquisition itself was a costly capital-allocation error.
Cyclicality 30 /100
Recurring SME subscription revenue with 96.9% NRR is largely defensive; minor exposure to SME insolvency cycle.
Leverage 8 /100
£4.8m net cash, no debt, small lease liability only [src: 2026-07-27 interim].

QUARTIX TECHNOLOGIES PLC (QTX) — Investment Research Note

Executive summary

Quartix is a UK-based subscription vehicle telematics vendor serving ~33,550 small-to-medium fleet customers (~343,000 vehicles) across the UK, France, USA and expanding continental European markets, with 97% of revenue recurring. Since founder Andy Walters returned as Executive Chairman in late 2023, the group has re-focused on organic ARR growth, delivered accelerating gross margins (80.0% H1 2026), and grown ARR by 11–14% p.a. while more than doubling free cash flow between 2024 and 2025. The most important valuation point today: this is a genuinely high-quality, cash-generative, net-cash subscription business trading at a modest premium to a fair intrinsic value — attractive to a quality-at-a-reasonable-price investor, but with only tangential AI exposure.

Fair value estimate

Range: 260p – 320p per share, implied market cap £126m–£155m.

  • Methodology: blended DCF and forward P/E cross-check.
    • Forward earnings multiple: FY26 consensus Adj EBIT £10.1m 2026-07-27 interim, ~23% underlying tax (H1 2026 underlying tax £1.1m on £4.8m PBT 2026-07-27 interim) → ~£7.8m normalised earnings ≈ 16.1p normalised EPS. At 16-20x forward earnings (justified by 97% recurring revenue, 80% gross margin, net-cash balance sheet, 24%+ Adj EBIT margin), fair value = 258p–322p.
    • EV/EBITDA cross-check: FY26e EBITDA guidance ~£15m 2026-07-08 trading; 8-10x = £120-150m EV + £5m net cash = 258p–320p.
    • FCF cross-check: FY25 FCF £5.2m 2026-03-25 final; FY26 guidance £4.9m 2026-07-08 trading. At 4-5% FCF yield fair range = 200p-260p (lower end of range).
  • Central estimate: 290p per share / £141m mcap.
  • vs. current mcap £122.6m: absolute upside ≈ +18.5% to mid, range −0% to +30%.

Sector context

  • ICB Technology / Software & Computer Services classification is accurate: this is subscription vertical SaaS with an integrated hardware element (now on-balance-sheet under IAS 16 following the 2025 FRC review 2026-03-25 final).
  • Quality profile is above typical AIM technology peers: consistently profitable, cash-generative, net cash, high recurring revenue, low customer concentration (largest client <1% of sales 2025-10-06 trading).
  • Listed peer set is thin. Nearest UK-listed comparators: Microlise Group (SAAS) (larger fleet tech, lower gross margin), Trakm8 (TRAK) (smaller, more volatile), AB Dynamics (ABDP) (adjacent automotive tech, richer valuation). International peers Samsara (US) and Geotab (private) operate at very different scale and multiples.

Investment thesis

  1. High-quality subscription compounder trading at a reasonable price. 97% recurring revenue, 80% gross margin (H1 2026, restated basis), 24% Adj EBIT margin, £4.8m net cash and NRR of 96.9% 2026-07-27 interim. Blended forward multiple of ~15x earnings understates the durability of the cash flow stream.
  2. Continental Europe is the growth engine and it is executing. Italy ARR +39%, Spain +31%, Germany +20%, France +14% TTM to June 2026 2026-07-27 interim; management is stepping up investment into H2 2026 and 2027 including dashcam launch in Continental Europe 2026-07-27 interim. This structurally lifts group growth above the mid-single-digit UK rate.
  3. Operational discipline post-Konetik cleanup. The Konetik acquisition was written off in full 2024-03-04 final and management pivoted decisively back to core telematics; TCSV17/18 hardware refresh cuts unit cost, FY25 FCF doubled to £5.2m 2026-03-25 final, and the group returned 10p total dividend for 2025 (vs 4.5p 2024).

Key risks

  1. AI-agent substitution risk to the value proposition is low but not zero. The core buyer is a tradesperson SME; if a future AI-driven fleet automation product from a hyperscaler bundled telematics as a commodity feed, per-vehicle ARR could compress. Not disclosed but inferred.
  2. Slowing NRR and US churn. Group NRR slipped to 96.9% from 97.3% 2026-07-27 interim; US subscription base declined 3% TTM. If UK NRR continues to drift (100% → 99.4% 2026-07-27 interim), the compounding thesis weakens.
  3. Accounting policy volatility raises watch-flags. The FRC-driven IAS 16 restatement in 2025 2026-03-25 final materially altered the P&L geography and produced a £1.1m prior-year tax adjustment in H1 2026 2026-07-27 interim. The auditors' report is unqualified but the episode shows that reported EBITDA has been sensitive to accounting choices.

Operating leverage

The cost base is substantially fixed — ARR per employee reached £220,000 in H1 2026 (from £198k a year earlier 2026-07-27 interim), gross margin is 80%, and administrative expenses grew only 2% on 12% revenue growth in H1 2026 2026-07-27 interim. Under IAS 16, incremental subscriptions carry an immediate cash cost (unit + install) but are depreciated over 7 years, so reported P&L operating leverage on ARR growth is high: H1 2026 gross profit grew £1.9m on £2.1m revenue increase — near-90% incremental gross margin. A 10-20% revenue beat above the current £40.3m consensus would plausibly add £3–5m to Adj EBIT (£10.1m → £13–15m), i.e. a 30-50% profit uplift — meaningful but not multiples of profit, because management would likely reinvest a portion into sales/marketing (as the H1 2026 £1.0m S&M step-up demonstrates 2026-07-27 interim). This is a solid but not extreme operating-leverage story: the "spare capacity" is real, but growth is a steady 11-14% ARR compounder, not a runaway top-line.

Value-trap signals

None identified of concern. Minor watch-items: (i) the FRC restatement is not a value trap but a reminder to read the reconciliations; (ii) US and UK NRR softness bears monitoring; (iii) Konetik was a poor capital-allocation decision, since fully cleaned up.

Earnings vs. expectations

Across the 2024–2026 period Quartix has consistently met or modestly beaten market expectations. H1 2025: management raised guidance to "slightly ahead" 2025-07-24 interim. FY 2025 trading update Jan 2026: revenue and EBITDA "ahead of current market expectations" 2026-01-08 trading update. H1 2026 interim confirmed FY market expectations of £40.3m rev / £10.1m Adj EBIT / £4.9m FCF 2026-07-27 interim. The 2023 Konetik-related impairment was the last material downside surprise, and the last four consecutive result cycles have been in-line to marginally ahead. Track record supports moderate confidence in the current-year guide.

Conviction

4 — high. Anchoring the fair value: (i) 97% recurring revenue with 22+ years of subscription-based track record gives high confidence in near-term revenue; (ii) management guidance has been reliable for four consecutive reporting cycles; (iii) multiple valuation methodologies (P/E, EV/EBITDA, FCF yield) converge on £120–150m. Limiting the conviction: (i) the recent IAS 16 restatement means historical margin trajectory needs re-normalising, adding noise to the multi-year picture; (ii) the terminal growth rate for a mature SME telematics business is uncertain — 4–5% or lower is plausible in a mature market, which caps DCF-implied value.

Filings consulted · 41

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-07-27Interim Results2026-07-27_9687593_interim-results.md0.90
  2. 2026-07-08Trading Statement2026-07-08_9657144_trading-statement.md0.85
  3. 2026-04-22Trading Statement2026-04-22_9531417_trading-statement.md0.85
  4. 2026-04-22Result OF Agm2026-04-22_9533523_result-of-agm.md0.30
  5. 2026-03-25Final Results2026-03-25_9490311_final-results.md1.00
  6. 2026-01-08Trading Update2026-01-08_9340091_trading-update.md0.72
  7. 2025-10-06Trading Statement2025-10-06_9151398_trading-statement.md0.72
  8. 2025-07-24Interim Results2025-07-24_8996403_interim-results.md0.58
  9. 2025-07-03Trading Statement2025-07-03_8961168_trading-statement.md0.55
  10. 2025-04-07Trading Statement2025-04-07_8816041_trading-statement.md0.55
  11. 2025-03-31Result OF Agm2025-03-31_8805928_result-of-agm.md0.20
  12. 2025-03-31Agm Trading Statement2025-03-31_8804101_agm-trading-statement.md0.55
  13. 2025-03-03Final Results2025-03-03_8758857_final-results.md0.65
  14. 2025-02-13Investor Presentation Via Investor Meet Company2025-02-13_8735594_investor-presentation-via-investor-meet-company.md0.46
  15. 2025-01-13Trading Statement2025-01-13_8684163_trading-statement.md0.55
  16. 2024-10-15Trading Statement2024-10-15_8485777_trading-statement.md0.55
  17. 2024-07-29Interim Results2024-07-29_8334600_interim-results.md0.58
  18. 2024-07-08Trading Statement2024-07-08_8297949_trading-statement.md0.38
  19. 2024-03-27Result OF Agm2024-03-27_8110630_result-of-agm.md0.14
  20. 2024-03-27Agm Trading Statement And Directorate Change2024-03-27_8108582_agm-trading-statement-and-directorate-change.md0.38
  21. 2024-03-04Final Results2024-03-04_8067446_final-results.md0.45
  22. 2024-01-09Trading Statement2024-01-09_7980157_trading-statement.md0.38
  23. 2023-10-06Trading Update2023-10-06_7800192_trading-update.md0.38
  24. 2023-09-15Acquisition OF Konetik Gmbh2023-09-15_7757064_acquisition-of-konetik-gmbh.md0.34
  25. 2023-07-31Interim Results2023-07-31_7664098_interim-results.md0.41
  26. 2023-07-10Interim Results Timetable And Trading Update2023-07-10_7621645_interim-results-timetable-and-trading-update.md0.23
  27. 2023-03-24Result OF Agm2023-03-24_7331327_result-of-agm.md0.07
  28. 2023-03-24Agm Trading Statement2023-03-24_7280396_agm-trading-statement.md0.21
  29. 2023-02-27Final Results2023-02-27_7235717_final-results.md0.25
  30. 2023-01-11Trading Statement2023-01-11_7392214_trading-statement.md0.21
  31. 2022-10-10Trading Update2022-10-10_7255657_trading-update.md0.21
  32. 2022-07-27Interim Results2022-07-27_7179671_interim-results.md0.23
  33. 2022-07-11Interim Results Timetable And Trading Update2022-07-11_6923349_interim-results-timetable-and-trading-update.md0.23
  34. 2022-03-23Result OF Agm2022-03-23_7049566_result-of-agm.md0.07
  35. 2022-03-23Agm Trading Statement2022-03-23_7006189_agm-trading-statement.md0.21
  36. 2022-02-28Final Results2022-02-28_6959902_final-results.md0.25
  37. 2022-01-10Trading Statement2022-01-10_6805707_trading-statement.md0.21
  38. 2021-10-22Ceo Succession Update And Trading Update2021-10-22_6525843_ceo-succession-update-and-trading-update.md0.21
  39. 2021-10-13Ceo Succession Update And Trading Update2021-10-13_6766401_ceo-succession-update-and-trading-update.md0.21
  40. 2021-07-28Interim Results2021-07-28_6781624_interim-results.md0.09
  41. 2021-07-07Interim Results Timetable And Trading Update2021-07-07_6541699_interim-results-timetable-and-trading-update.md0.09

This research note was authored by a large language model after reading 34 regulatory filings published between 2021-07-07 and 2026-07-27. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.